The former NFL star says biotech firm Colossal Biosciences, which he invested in, cloned his pit bull mix using DNA collected ...

T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers. Solid tumors, which account for around 90% of all adult cancers, remain a ...

The field of fish conservation is grappling with the complex challenges posed by human-modified landscapes. As habitats undergo rapid transformation due to ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

Azalea Therapeutics, Inc., a biotechnology company redefining precision genomic medicines in vivo, today announced its official launch and completion of $82 million in seed and Series A financing to ...

Expanded Dose Exploration in Part A and Dose Escalation in Part B of BEAM-302 Phase 1/2 Study in Alpha-1 Antitrypsin Deficiency Ongoing; Updated ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

We are a society in desperate need of healing; these days, we cannot even find agreement in diagnosis. Consider the issue of vaccination, which raises the specter of science in conflict with ...

Cas9 gene editing and artificial intelligence to create compact tomato plants optimized for vertical farming in response to the dual challenges of climate change and urbanization.

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by chemist Brian Liau and his collaborators at Harvard offers an ...

We are thrilled to welcome Matt to our leadership team,” said Allan Reine, M.D., Chief Executive Officer of Prime Medicine. “Business development has been – and will continue to be – a core pillar of ...

Vinay Prasad, chief of the FDA’s Center for Biologics Evaluation and Research, is planning to publish a paper this month to ...